Recommendations on the use of intravesical hyaluronic acid instillations in bladder pain syndrome

• Published in: Actas urológicas españolas (English ed.) 2022-04, Vol.46 (3), p.131-137
• Main Authors: Madurga Patuel, B., González-López, R., Resel Folkersma, L., Machado Fernández, G., Adot Zurbano, J.M., Bonillo, M.Á., Vozmediano Chicharro, R., Zubiaur Líbano, C.
• Format: Article
• Language: English
• Subjects: Administration, Intravesical; Bladder pain syndrome; Cistitis intersticial; Cystitis, Interstitial - drug therapy; Female; Humans; Hyaluronic acid; Hyaluronic Acid - therapeutic use; Instilaciones endovesicales; Interstitial cystitis; Intravesical instillations; Male; Pain Measurement; Recomendaciones; Recommendations; Síndrome del dolor vesical; Tratamiento; Treatment; Urodynamics; Ácido hialurónico
• ISSN: 2173-5786; 2173-5786
• DOI: 10.1016/j.acuroe.2022.02.007

Bladder pain syndrome (BPS) is a complex syndrome, without a clearly defined etiology that encompasses different entities, such as interstitial cystitis. This leads to difficulties in establishing a precise definition, obtaining accurate prevalence data, and defining diagnostic criteria and standardized assessment methods. Moreover, there is no consensus regarding the treatment of BPS. Intravesical instillations with hyaluronic acid (HA) are an option, although no specific recommendations have been made yet. To synthesize the scientific evidence on the therapeutic options available for BPS and to establish a work plan and recommendations for the use of intravesical instillations with HA. The Spanish Association of Urology, through the Functional, Female, and Urodynamic Urology Group, created a commission of experts. This commission was in charge of reviewing literature (evidence), agreeing on the work plan, and proposing recommendations. There is great variability in literature on the treatment of BPS, without a standard regimen of intravesical instillation with HA (frequency and duration of initial and maintenance treatment). Intravesical HA instillations (usual dose of 40 mg) are effective and safe. They can be combined with other options, with efficacy still to be determined in some cases. Treatment is divided into several initial weekly sessions, followed by maintenance treatment, usually monthly (unestablished duration of cycles). Recommendations on the management of BPS were agreed, with diagnostic criteria and guidelines for treatment with intravesical HA (initiation, reassessment, and follow-up). El síndrome del dolor vesical (SDV) es un síndrome complejo, sin etiología claramente establecida, que engloba diferentes entidades como la cistitis intersticial. Esto conlleva dificultades para establecer una definición precisa, obtener datos de prevalencia exactos y definir criterios diagnósticos y métodos estandarizados de estudio. Tampoco existe homogeneidad sobre el tratamiento del SDV. Las instilaciones endovesicales con ácido hialurónico (AH) son una opción, sin aún recomendaciones específicas. Sintetizar la evidencia científica sobre las opciones terapéuticas disponibles para el SDV y consensuar un plan de trabajo y unas recomendaciones para el uso de las instilaciones endovesicales con AH. La Asociación Española de Urología, a través del Grupo de Urología Funcional, Femenina y Urodinámica, generó una comisión de expertos. Esta comisión fue la enca